Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance

Clinical Infectious Diseases

Volumn 33, Issue 6, 2001, Pages 797-805

  Moroney, John F ^a   Fiore, Anthony E ^a   Harrison, Lee H ^c   Patterson, Jan E ^d   Farley, Monica M ^b   Jorgensen, James H ^d   Phelan, Maureen ^a   Facklam, Richard R ^a   Cetron, Martin S ^a   Breiman, Robert F ^a   Kolczak, Margarette ^a   Schuchat, Anne ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; IMIPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN; TIMENTIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; HEALTH SURVEY; HUMAN; INTENSIVE CARE UNIT; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIVARIATE ANALYSIS; NEWBORN; OUTCOMES RESEARCH; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CASE-CONTROL STUDIES; CEFOTAXIME; CEPHALOSPORIN RESISTANCE; CHILD; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; HOSPITALIZATION; HUMANS; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 17944367298     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322623     Document Type: Article

References (33)

1. Hospitalization decision in patients with community-acquired pneumonia: A prospective cohort study
2. Community-acquired pneumonia
3. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy
4. Predicting death in patients hospitalized for community-acquired pneumonia
5. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio
6. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
7. Geographic variation in penicillin resistance in Streptococcus pneumoniae - Selected sites, United States, 1997
8. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children
9. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain
10. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease
11. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta
12. Bacterial meningitis in the United States in 1995
13. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
14. Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae
15. Assessment of the completeness and accuracy of computer medical records in four practices committed to recording data on computer
16. Pneumococcal disease during HIV infection: Epidemiologic, clinical, and immunologic perspectives
17. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents
18. Pneumococcal bacteremia in adults: A 14-year experience in an inner-city university hospital
19. APACHE II: A severity of disease classification system
20. Pediatric risk of mortality (PRISM) score
21. Treatment of community-acquired pneumonia - IDSA guidelines
22. Community-acquired pneumonia in adults: Guidelines for management
23. Epidemiology of community-acquired respiratory tract infections in adults: Incidence, etiology, and impact
24. Pneumococcal pneumonia including diagnosis and therapy of infection caused by penicillin-resistant strains
25. Consensus: Management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin
26. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis
27. Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
28. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae
29. Penicillin-nonsusceptible Streptococcus pneumoniae at San Francisco General Hospital
30. Increasing prevalence of multi-drug resistant Streptococcus pneumoniae in the United States
31. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
32. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine